Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer

Completed

Conditions studied: Lung Cancer

In brief

RATIONALE: Detecting very early metastases in bone marrow and/or lymph nodes may help doctors plan better treatment for non-small cell lung cancer. PURPOSE: Clinical trial to detect the presence of metastatic cancer in patients with stage I non-small cell lung cancer that has not been previously treated.

Key facts

Study ID

NCT00003006

Run by

Alliance for Clinical Trials in Oncology

People needed

501

Starts

1997-05-01

Expected to finish

2010-06-01

Last updated by the study team

2016-06-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Holden Comprehensive Cancer Center at The University of Iowa — Iowa City, Iowa, United States
• Marlene & Stewart Greenebaum Cancer Center, University of Maryland — Baltimore, Maryland, United States
• University of Minnesota Cancer Center — Minneapolis, Minnesota, United States
• University of Minnesota Medical School — Minneapolis, Minnesota, United States
• Ellis Fischel Cancer Center - Columbia — Columbia, Missouri, United States
• Barnes-Jewish Hospital — St Louis, Missouri, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• State University of New York - Upstate Medical University — Syracuse, New York, United States
• Lineberger Comprehensive Cancer Center, UNC — Chapel Hill, North Carolina, United States
• Duke Comprehensive Cancer Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.